Emergency department (ED) presentations are associated with higher cancer mortality. This study aimed to investigate the prevalence, frequency, and risk factors in Australian patients diagnosed ...

Methods This data-linkage cohort study examined adult patients presenting to the ED at the Royal Melbourne and Western Health hospitals within 12 months of a malignant skin cancer diagnosis.

A new study explores a one-and-done radiotherapy for non-melanoma skin cancer – no scalpels, no stitches, just science.

Consumer Reports Too often, Black patients get late diagnoses of deadly skin cancer Surviving begins with knowing what to look for — and where. The following offers guidance on skin self-checks.

Primary malignant melanoma of the esophagus (PMME) is a rare type of gastrointestinal melanoma characterized by its aggressive nature and poor prognosis, with a 5-year survival rate of less than 5%.

This study excluded uveal melanoma, but included all other subtypes provided they had progressed on previous therapy. With this broad population of patients with melanoma, those who received an ...

Our study results reveal a unique vulnerability in melanoma patients with neurofibromin 1 mutations, that an overexpression of the epidermal growth factor receptor pathway is essential for their ...

ASCO 2025 Oral Presentation: Innovent Biologics Announces Updated Data of IBI363 (First-in-class PD-1/IL-2α -bias Bispecific Antibody Fusion Protein) from Phase 1 and 2 Clinical Studies on ...

About Melanoma Melanoma is a malignant tumor that develops from melanocytes. While it accounts for only 3% of all skin cancers, it has the highest mortality rate and is the most prone to metastasis.

The DecisionDx®-Melanoma test offers a precise look at a patient’s unique tumor biology, and enables patients and their care providers to co-create a personalized care plan.

The book said that the Biden family wanted to keep Beau Biden’s cancer diagnosis a secret and misled the media about his condition.

Droplet digital polymerase chain reaction (PCR) measurements of circulating tumor DNA (ctDNA) identify patients with stage III melanoma who are at high risk for early recurrence during adjuvant ...